Evidence for large-scale gene-by-smoking interaction effects on pulmonary function.

File Description SizeFormat 
dyw318.pdfPublished version628.86 kBAdobe PDFDownload
Title: Evidence for large-scale gene-by-smoking interaction effects on pulmonary function.
Author(s): Aschard, H
Tobin, MD
Hancock, DB
Skurnik, D
Sood, A
James, A
Vernon Smith, A
Manichaikul, AW
Campbell, A
Prins, BP
Hayward, C
Loth, DW
Porteous, DJ
Strachan, DP
Zeggini, E
O'Connor, GT
Brusselle, GG
Boezen, HM
Schulz, H
Deary, IJ
Hall, IP
Rudan, I
Kaprio, J
Wilson, JF
Wilk, JB
Huffman, JE
Hua Zhao, J
De Jong, K
Lyytikäinen, LP
Wain, LV
Jarvelin, MR
Kähönen, M
Fornage, M
Polasek, O
Cassano, PA
Barr, RG
Rawal, R
Harris, SE
Gharib, SA
Enroth, S
Heckbert, SR
Lehtimäki, T
Gyllensten, U
Society Scientific Group, U
Jackson, VE
Gudnason, V
Tang, W
Dupuis, J
Soler Artigas, M
Joshi, AD
London, SJ
Kraft, P
Item Type: Journal Article
Abstract: BACKGROUND: Smoking is the strongest environmental risk factor for reduced pulmonary function. The genetic component of various pulmonary traits has also been demonstrated, and at least 26 loci have been reproducibly associated with either FEV1 (forced expiratory volume in 1 second) or FEV1/FVC (FEV1/forced vital capacity). Although the main effects of smoking and genetic loci are well established, the question of potential gene-by-smoking interaction effect remains unanswered. The aim of the present study was to assess, using a genetic risk score approach, whether the effect of these 26 loci on pulmonary function is influenced by smoking. METHODS: We evaluated the interaction between smoking exposure, considered as either ever vs never or pack-years, and a 26-single nucleotide polymorphisms (SNPs) genetic risk score in relation to FEV1 or FEV1/FVC in 50 047 participants of European ancestry from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) and SpiroMeta consortia. RESULTS: We identified an interaction (βint = -0.036, 95% confidence interval, -0.040 to -0.032, P = 0.00057) between an unweighted 26 SNP genetic risk score and smoking status (ever/never) on the FEV1/FVC ratio. In interpreting this interaction, we showed that the genetic risk of falling below the FEV 1: /FVC threshold used to diagnose chronic obstructive pulmonary disease is higher among ever smokers than among never smokers. A replication analysis in two independent datasets, although not statistically significant, showed a similar trend in the interaction effect. CONCLUSIONS: This study highlights the benefit of using genetic risk scores for identifying interactions missed when studying individual SNPs and shows, for the first time, that persons with the highest genetic risk for low FEV1/FVC may be more susceptible to the deleterious effects of smoking.
Publication Date: 12-Jan-2017
Date of Acceptance: 10-Oct-2016
URI: http://hdl.handle.net/10044/1/45110
DOI: https://dx.doi.org/10.1093/ije/dyw318
ISSN: 1464-3685
Publisher: Oxford University Press (OUP)
Journal / Book Title: International Journal of Epidemiology
Copyright Statement: © 2017 The Author(s). Published by Oxford University Press on behalf of the International Epidemiological Association. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: FEV1/FVC
genetic risk score
gene–environment interaction
smoking
Epidemiology
0104 Statistics
1117 Public Health And Health Services
Publication Status: Published
Conference Place: England
Article Number: dyw318
Appears in Collections:Faculty of Medicine
Epidemiology, Public Health and Primary Care



Items in Spiral are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commons